Companies / Igi Laboratories, Inc
Igi Laboratories, Inc
IGTLGTCIK 352998
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Mar 5, 2015 | Life Sciences Opportunities Fund II LP 10% owner | Sell Open-market sale | Common Stock | $16.88M | -1.7M -16.87% | 8,356,988 | high |
| Mar 5, 2015 | Life Sciences Opportunities Fund II LP 10% owner | Sell Open-market sale | Common Stock | $3.02M | -304K -16.88% | 1,494,873 | medium |
| May 27, 2021 | Pate R Carter Director | Buy Open-market buy | Common Stock | $16.5K | +30K | 30,000 | low |
| Jul 16, 2021 | Yachmetz Philip K Executive | Other Withheld for taxes | Common Stock | $1.2K | -3K -33.90% | 5,179 | low |
| Jul 16, 2021 | Yachmetz Philip K Executive | Other Withheld for taxes | Common Stock | $1.2K | -3K -33.91% | 5,176 | low |
| Jul 16, 2021 | Yachmetz Philip K +1 co-filer Executive | Exercise Option exercise | Common Stock | $0 | +8K | 7,835 | low |
| Feb 11, 2015 | Grenfell-Gardner Jason CEO | Grant Grant or award | Stock Option | — | +43K | 42,500 | low |
| Feb 11, 2015 | Grenfell-Gardner Jason CEO | Grant Grant or award | Stock Option | — | +180K | 180,000 | low |